What Is Pelvic Exenteration?

Pelvic exenteration is one of the most extensive operations used in cancer treatment. It is considered for carefully selected patients with locally advanced or recurrent pelvic cancer when complete surgical removal offers a realistic possibility of long-term disease control or cure.

Unlike a standard operation involving a single organ, pelvic exenteration may require removal of the tumor together with several nearby organs or structures en bloc, meaning together as one specimen, to achieve clear cancer-free margins.

Depending on the location and extent of the cancer, surgery may involve the rectum and anus, bladder and urinary tract, reproductive organs, pelvic floor, pelvic sidewall, sacrum, or other nearby structures.

The main oncological goal is an R0 resection—complete removal of the cancer with no tumor cells found at the microscopic edges of the removed tissue.

Modern pelvic exenteration is therefore not defined simply by how many organs are removed. The operation is tailored to where the cancer is located and what it involves. Structures that need to be removed for complete cancer clearance are included, while organs and function are preserved whenever this can be done safely.

Pelvic exenteration is traditionally classified as:

• Anterior Pelvic Exenteration – removal of anterior pelvic organs, usually including the bladder and reproductive structures, while preserving the rectum when possible.
• Posterior Pelvic Exenteration – removal of posterior pelvic structures, including the rectum, while preserving the bladder when possible.
• Total Pelvic Exenteration – removal of both the lower gastrointestinal and urinary organs within the pelvis.

These classifications provide a general description, but modern operations are often more individualized. Some patients require less extensive surgery, while others may need extended pelvic resection involving the pelvic sidewall, bone, major blood vessels, or other structures.

The aim is not to perform the largest possible operation. It is to perform the operation needed to remove the cancer completely while balancing oncological benefit, surgical risk, function, recovery, and quality of life.

 

When Is Pelvic Exenteration Recommended?

Pelvic exenteration is mainly considered for patients with locally advanced or recurrent pelvic cancer when complete removal of all clinically significant disease appears possible.

It may be considered when a less extensive operation would leave cancer behind or when previous treatments such as chemotherapy or radiotherapy have not provided lasting local control.

Pelvic exenteration may have a role in selected patients with:

• Rectal cancer
• Cervical cancer
• Endometrial cancer
• Vaginal cancer
• Vulvar cancer
• Bladder cancer
• Anal cancer
• Prostate cancer
• Selected pelvic soft-tissue or bone sarcomas
• Other uncommon pelvic malignancies

Its role differs considerably between these cancers. The decision depends not only on anatomy, but also on tumor biology, previous treatment, pattern of recurrence, likelihood of complete removal, available alternative treatments, and the patient's overall condition and goals.

Pelvic Exenteration in Ovarian and Related Cancers

In ovarian cancer and related Müllerian cancers, pelvic exenteration is generally not used as a separate standard treatment because disease may involve several areas of the abdomen.

However, modified posterior pelvic exenteration or other en bloc pelvic resections may form part of cytoreductive surgery when disease involving the rectosigmoid colon and reproductive organs must be removed to achieve complete macroscopic cytoreduction.

In this setting, pelvic exenteration is best understood as one component of an individualized cytoreductive operation rather than as a separate treatment for ovarian cancer.

Repeat Pelvic Exenteration

Repeat pelvic exenteration is uncommon but may be considered in highly selected patients who develop another localized pelvic recurrence after previous exenterative surgery. Whether another operation is appropriate depends on the location and extent of recurrence, previous surgery and radiotherapy, disease elsewhere in the body, the patient’s overall health and functional reserve, and—most importantly—whether another complete (R0) resection appears realistically achievable.

Such cases are particularly complex and should be evaluated individually at a specialist center experienced in recurrent pelvic cancer and extended pelvic surgery.

Pelvic Exenteration for Symptom Control

Pelvic exenteration is primarily performed with curative intent.

In exceptional circumstances, however, advanced pelvic cancer may cause severe problems such as:

• Uncontrolled bleeding
• Recurrent pelvic infection
• Complex fistulas
• Bowel or urinary obstruction
• Severe discharge
• Uncontrolled pain
• Major impairment of daily function

Palliative exenteration may occasionally be considered when less invasive treatments cannot adequately control these symptoms.

Because recovery can be prolonged and complications can be substantial, the possible benefit must be weighed carefully against life expectancy, surgical burden, recovery time, expected symptom relief, and the patient's priorities.

Less invasive symptom-control options should always be considered when appropriate.

 

Who May Be a Candidate?

Careful patient selection is essential.

Pelvic exenteration is most likely to be considered when:

• Complete removal of all clinically significant disease appears realistically achievable.
• An R0 resection is considered possible.
• No less extensive treatment offers a similar chance of cure or durable disease control.
• The expected benefit justifies the magnitude and functional consequences of surgery.
• The patient is medically and physically able to tolerate major surgery and recovery.
• The case has been reviewed by an experienced multidisciplinary cancer team.

Other important considerations include:

• Tumor type and biological behavior
• Whether the disease is primary or recurrent
• Previous surgery, radiotherapy, and systemic treatment
• Regional lymph-node involvement
• Relationship of the tumor to the pelvic sidewall, sacrum, nerves, blood vessels, ureters, bladder, and bowel
• Nutritional and physical condition
• Expected bowel and urinary function after reconstruction
• Patient preferences and treatment goals

The strongest rationale for curative-intent exenteration is generally when disease can be completely treated and there is no uncontrolled distant spread.

However, limited disease outside the pelvis does not automatically exclude surgery in every patient. In highly selected situations, limited metastatic disease that can also be completely treated may be incorporated into a broader curative-intent strategy.

These decisions require individualized assessment at a specialist center.

 

When May Pelvic Exenteration Not Be Appropriate?

Pelvic exenteration is unlikely to provide meaningful benefit when complete cancer removal cannot reasonably be achieved or when the expected surgical and functional burden outweighs the likely oncological benefit.

Surgery may not be appropriate when there is:

• Widespread metastatic disease that cannot be effectively treated
• Extensive peritoneal disease not amenable to meaningful curative treatment
• Pelvic disease that cannot be removed with acceptable margins
• Involvement of critical structures that makes complete resection impossible or disproportionately harmful
• Severe medical illness or frailty that makes recovery from major surgery unlikely
• Poor nutritional or physical reserve that cannot be sufficiently improved before treatment

Importantly, findings such as pelvic sidewall involvement, hydronephrosis, sacral invasion, selected nodal disease, or limited metastatic disease do not automatically rule out surgery in every specialist center.

The key question is not simply which structure is involved. It is whether the disease can be treated completely enough to provide meaningful benefit at an acceptable surgical and functional cost.

 

The Importance of Achieving an R0 Resection

One of the strongest predictors of successful treatment is whether an R0 resection can be achieved.

R0 means that the cancer has been removed completely and no tumor cells are found at the microscopic surgical margins.

When cancer remains at the edge of the specimen or visible disease is left behind, the risk of recurrence is higher.

For this reason, the surgical team must consider not only whether an operation is technically possible, but whether it is likely to remove the cancer completely.

This may require removing adjacent structures that are directly involved rather than separating the tumor from them.

At the same time, uninvolved organs should not be removed simply because an exenteration is being performed. Modern surgery aims for complete cancer removal while preserving organs and function whenever this is oncologically safe.

 

Preoperative Assessment

Before pelvic exenteration, the multidisciplinary team must answer two fundamental questions: Can the cancer be completely removed with acceptable surgical margins, and can the patient safely tolerate the operation and recovery?

Assessment therefore focuses on tumor extent and resectability, previous treatments, physical reserve, and the structures that may need to be included in the operation.

Determining Whether Complete Resection Is Possible

Imaging and previous treatment records are reviewed carefully to determine how far the cancer extends and whether complete removal appears realistic.

Assessment may include:

• High-resolution pelvic MRI
• Contrast-enhanced CT of the chest, abdomen, and pelvis
• PET/CT in selected patients
• CT angiography when major vascular involvement is suspected
• Review of pathology, previous imaging, operative reports, chemotherapy, and radiotherapy records

Particular attention is given to involvement of the pelvic sidewall, sacrum, major blood vessels, ureters, bladder, bowel, pelvic floor, and reproductive organs, because these structures may affect the ability to obtain clear margins.

Imaging cannot always show the full extent of disease, particularly after previous surgery or radiotherapy. Occasionally, the final extent of tumor involvement—and whether complete resection is achievable—becomes fully clear only during surgical exploration.

Endoscopic and Additional Evaluation

Depending on the location and extent of disease, additional evaluation may include:

• Cystoscopy
• Colonoscopy or flexible sigmoidoscopy
• Examination under anesthesia
• Biopsy when confirmation would change treatment
• Additional specialist assessment when required

These investigations are selected according to the individual pattern of disease rather than performed routinely in every patient.

Assessing Fitness for Major Surgery

Pelvic exenteration is physically demanding, so assessment must also determine whether the patient has sufficient reserve to tolerate surgery and recovery.

Preoperative evaluation may include:

• Complete blood count
• Kidney and liver function and other biochemical tests
• Coagulation or blood glucose testing when indicated
• Blood group and preparation for transfusion when appropriate
• ECG
• Additional cardiac or pulmonary testing when required

An anesthesiologist will review medical conditions, medications, allergies, previous anesthesia, and heart and lung function.

For particularly extensive operations, planning may also include advanced monitoring, blood-product preparation, specialized pain management, and postoperative intensive or high-dependency care.

 

Preparing for Pelvic Exenteration

Once surgery is considered appropriate and feasible, preparation focuses on reducing avoidable risks, improving physical and nutritional condition, anticipating the procedures that may be required, and preparing for recovery and long-term changes.

Preparation is individualized according to previous treatment, overall health, expected organ removal, reconstruction, and the possibility of bowel or urinary diversion.

Nutrition and Prehabilitation

Patients with locally advanced or recurrent pelvic cancer may have weight loss, anemia, loss of muscle mass, chronic symptoms, or effects from previous treatment.

Preparation may include:

• Nutritional assessment and support
• Treatment of anemia or nutritional deficiencies
• Physical prehabilitation
• Optimization of medical conditions
• Smoking cessation and reduction of harmful alcohol use
• Psychological support

The aim is to enter surgery with the best nutritional, physical, and functional reserve reasonably achievable without unnecessarily delaying cancer treatment.

Medications Before Surgery

Your healthcare team should know about all medications and supplements you take.

Particular attention may be required for blood thinners, antiplatelet drugs, diabetes medications including GLP-1 receptor agonists, blood-pressure medications, steroids, supplements, and recent anticancer treatments.

Some medications may need to be stopped or adjusted, while others should continue.

Do not change medications specifically for surgery unless instructed by your healthcare team.

Planning for Stomas and Urinary Diversion

Depending on which organs must be removed, pelvic exenteration may require a permanent colostomy, urinary diversion, or both.

If a bowel stoma is anticipated, a specialist stoma nurse can provide education and mark an appropriate site before surgery.

If the bladder must be removed, the urinary reconstruction will also be discussed. One commonly used option is an ileal conduit, in which urine drains through a stoma into an external pouch.

Counseling before surgery should address how these changes may affect self-care, clothing, work, exercise, travel, intimacy, body image, and everyday life.

Planning Reconstructive Surgery

Extended pelvic surgery, particularly after previous radiotherapy, may leave significant pelvic or perineal tissue defects.

When necessary, reconstruction may use healthy, well-vascularized tissue flaps to fill empty pelvic space, reconstruct the perineum or vagina, and support wound healing.

If reconstructive or other specialist procedures are likely to be needed, the relevant teams should ideally be involved before surgery.

Understanding the Possible Extent of Surgery

The final operation may differ from what appears necessary on preoperative imaging.

Before surgery, patients should understand which structures are expected to be removed, what additional procedures may become necessary, and what the surgical team hopes to preserve whenever safely possible.

Informed consent should include discussion of:

• The goal of achieving an R0 resection
• Expected and possible additional organ removal
• Bowel or urinary reconstruction and possible stomas
• Reconstructive surgery when required
• Major complications and functional consequences
• Urinary, sexual, and reproductive effects
• Recovery and long-term anatomical changes
• Circumstances in which the operation may need to be modified or stopped

The aim is to remove what is necessary for effective cancer clearance while preserving structures and function whenever safely possible.

Planning for Recovery

Preparation should also include practical planning for after discharge, including home support, transportation, time away from work, stoma or urinary-diversion care, nutrition, rehabilitation, wound care, and follow-up.

Recovery is gradual and may continue for several months. Planning ahead can make the transition from hospital to home easier.

 

Multidisciplinary Planning

Pelvic exenteration should not be planned by a surgeon in isolation.

Successful treatment depends on selecting the right patient, determining the appropriate extent of surgery, anticipating reconstruction, and coordinating the specialties that may be required.

Depending on the operation, the multidisciplinary team may include specialists in:

• Surgical oncology
• Colorectal surgery
• Gynecologic oncology
• Urology
• Plastic and reconstructive surgery
• Vascular surgery
• Orthopedic or spinal surgery
• Medical oncology
• Radiation oncology
• Radiology
• Pathology
• Anesthesia and intensive care
• Nutrition
• Rehabilitation
• Specialist stoma care

Not every patient requires every specialty. The team is assembled according to the specific anatomical and oncological needs of the individual operation.

When surgery may involve the pelvic sidewall, sacrum, major blood vessels, urinary tract, bowel, reproductive organs, or major soft-tissue reconstruction, the appropriate specialists should ideally participate in planning before surgery.

The purpose is not simply to decide whether exenteration is technically possible. It is to determine whether complete tumor removal is realistic, what must be removed, what can safely be preserved, and whether the expected benefit justifies the surgical and functional consequences.

 

How Is Pelvic Exenteration Performed?

Pelvic exenteration is performed under general anesthesia and usually lasts several hours. The duration depends on the extent of disease, previous surgery or radiotherapy, the organs being removed, and the reconstruction required.

The operation generally begins with surgical exploration to confirm that the planned resection remains feasible.

When complete removal is possible, the tumor and directly involved structures are removed en bloc when necessary to maintain appropriate cancer surgery planes and obtain clear margins.

Depending on the disease, surgery may involve removal of:

• Rectum
• Anus and sphincter complex
• Bladder
• Distal ureters
• Uterus and cervix
• Ovaries and fallopian tubes
• Part or all of the vagina
• Prostate and seminal vesicles
• Pelvic floor muscles
• Pelvic sidewall tissues
• Sacrum or other pelvic bone
• Involved nerves or blood vessels in highly selected cases
• Other structures directly involved by cancer

Not every patient requires removal of all—or even most—of these structures.

The operation is individualized according to what must be removed to achieve complete cancer clearance.

 

Extended Pelvic Resection

Historically, cancers involving the pelvic sidewall, sacrum, major vessels, or other difficult structures were often considered unresectable.

Advances in imaging, anatomical understanding, reconstructive techniques, vascular and orthopedic surgery, and perioperative care have expanded what may be treated surgically in selected patients.

Pelvic Sidewall Resection and LEER

Selected cancers extending toward the pelvic sidewall may be considered for procedures such as Laterally Extended Endopelvic Resection (LEER) or other extended lateral pelvic resections.

These operations remove tissues beyond the usual boundaries of standard pelvic exenteration when this is necessary to achieve adequate margins.

Sacral Resection

Cancer involving the posterior pelvis may occasionally require en bloc sacrectomy.

The level and extent of sacral resection are important because higher resections can have greater effects on mobility, nerve function, bladder and bowel control, and overall surgical risk.

Vascular and Other Extended Resections

In highly selected patients, cancer involving major pelvic blood vessels or other complex structures may sometimes be treated with vascular resection and reconstruction or other specialized procedures.

These operations are considered only when the expected oncological benefit justifies the additional risk and possible functional consequences.

 

Reconstruction After Pelvic Exenteration

Removing the cancer is only one part of the operation. After resection, the surgical team may need to reconstruct the urinary tract, bowel, pelvic floor, perineum, or other tissues.

The reconstruction required depends on which structures have been removed.

Urinary Reconstruction

If the bladder is removed, urine needs a new route out of the body.

A commonly used option is an ileal conduit, in which a short segment of small intestine carries urine from the ureters to a stoma on the abdominal wall.

Other forms of urinary reconstruction may be appropriate in selected patients depending on anatomy, kidney function, previous treatment, and surgical goals.

Bowel Reconstruction

If the rectum can be preserved or bowel continuity can safely be restored, the bowel may be reconnected.

If the anus and sphincter complex must be removed, bowel continuity through the natural opening cannot be restored and a permanent colostomy is generally required.

A temporary stoma may also be used in selected patients to protect a new bowel connection while it heals.

Pelvic and Perineal Reconstruction

Large pelvic resections can leave empty space or soft-tissue defects, particularly after removal of the anus, pelvic floor, or previously irradiated tissue.

Reconstruction may use:

• Omentum
• Local tissue flaps
• Gracilis muscle or myocutaneous flaps
• Vertical rectus abdominis myocutaneous (VRAM) flaps
• Gluteal flaps
• Other reconstructive techniques

Bringing healthy, well-vascularized tissue into an irradiated area can help fill pelvic dead space and support healing.

No single reconstruction is appropriate for every patient.

 

Will I Need a Permanent Stoma?

It depends on which organs need to be removed.

If the rectum, anus, and anal sphincter are removed, a permanent colostomy will usually be required.

If the bladder is removed, a urinary diversion will also be needed. This may involve a urinary stoma such as an ileal conduit.

Not every pelvic exenteration requires both a bowel and urinary stoma. For example, if the rectum can be preserved during anterior pelvic exenteration, a permanent colostomy may not be necessary.

When there is a meaningful possibility of a stoma, patients should ideally meet a specialist stoma care nurse before surgery for education and stoma-site marking.

Living with a stoma requires adjustment, but many people return to work, exercise, travel, relationships, and other everyday activities after recovery.

 

Possible Risks and Complications

Pelvic exenteration is major surgery, and complications are relatively common despite modern surgical and perioperative care.

Possible complications include:

• Bleeding or need for blood transfusion
• Wound or pelvic infection
• Pelvic abscess
• Delayed wound healing or perineal wound breakdown
• Bowel or urinary leakage
• Temporary slowing of bowel function
• Bowel obstruction
• Blood clots in the legs or lungs
• Urinary infection or kidney problems
• Respiratory complications
• Stoma or urinary-diversion problems
• Hernia
• Chronic pelvic or perineal problems
• Need for additional procedures or reoperation

Risk varies according to the extent of cancer, number and type of organs removed, previous surgery or radiotherapy, reconstruction required, nutritional and physical condition, other medical problems, and the complexity of the operation.

The purpose of preoperative assessment is therefore not simply to determine whether someone can undergo surgery, but to reduce modifiable risks and decide whether the expected benefit justifies the overall treatment burden.

 

Recovery After Pelvic Exenteration

Recovery varies considerably from one person to another.

After particularly extensive surgery, some patients require initial care in an intensive-care or high-dependency unit. Others may be transferred directly to a specialist surgical ward.

Hospital stay commonly ranges from several days to several weeks, depending on the operation, reconstruction, recovery, and whether complications occur.

Early recovery may involve:

• Pain control
• Intravenous fluids
• Urinary catheters and surgical drains
• Stoma care
• Blood-clot prevention
• Early walking and physiotherapy
• Gradual return to eating and drinking
• Nutritional support
• Wound and reconstructive care

Recovery continues after discharge.

Fatigue, reduced strength and appetite, altered bowel or urinary function, and adjustment to stomas or other anatomical changes may continue for several months.

Return to driving, work, exercise, sexual activity, and other normal activities should be individualized according to recovery and the type of surgery performed.

 

Quality of Life After Pelvic Exenteration

Pelvic exenteration can cause major and permanent changes to the body, and these should be discussed openly before surgery.

Quality of life often declines during the early recovery period. Many patients then experience substantial improvement as healing progresses, strength returns, and they become more confident managing bowel or urinary diversion.

Some longer-term difficulties may involve:

• Sexual function
• Body image
• Urinary or bowel function
• Stoma-related concerns
• Physical stamina
• Chronic pain
• Emotional well-being

For some patients, successful treatment also relieves severe cancer-related symptoms such as pain, bleeding, fistula, infection, discharge, or obstruction, which can improve important aspects of everyday life.

Quality of life cannot be predicted simply by whether a person has a stoma.

Rehabilitation, stoma education, physiotherapy, nutrition, psychological care, sexual-health support, and realistic preparation before surgery can all help with long-term adjustment.

 

Sexual and Reproductive Function

Pelvic exenteration may significantly affect sexual and reproductive function.

Depending on the surgery, possible changes include:

• Vaginal anatomy or length
• Sexual sensation
• Erectile or ejaculatory function
• Fertility
• Menopause
• Body image
• Intimacy

When appropriate, vaginal reconstruction or other reconstructive procedures may be possible.

If future fertility is relevant, fertility-preservation options should be discussed before treatment whenever this can be done without compromising cancer care.

Sexual rehabilitation and specialist support can also form an important part of recovery and survivorship.

 

Treatment After Pelvic Exenteration

Whether additional cancer treatment is required depends on the primary cancer, final pathology, surgical margins, lymph-node findings, molecular characteristics, previous treatment, and risk of recurrence.

Some patients require no immediate additional treatment and enter surveillance.

Others may receive chemotherapy, targeted therapy, immunotherapy, hormonal treatment, radiotherapy, or another disease-specific treatment.

Many patients undergoing salvage pelvic exenteration have previously received pelvic radiotherapy, which can limit the amount of additional radiation that can safely be delivered.

However, previous radiation does not automatically make further radiotherapy impossible. Re-irradiation may be considered in carefully selected situations at experienced centers.

 

What Are the Expected Outcomes?

Pelvic exenteration can provide long-term disease control and, in selected patients, the possibility of cure.

Outcome depends on factors including:

• Type and biology of the cancer
• Whether disease is primary or recurrent
• Extent of pelvic disease
• Lymph-node involvement
• Disease elsewhere in the body
• Previous treatment
• Ability to achieve an R0 resection
• Postoperative complications
• Overall health and physical reserve

Because pelvic exenteration is performed for several biologically different cancers, there is no single survival percentage that accurately applies to every patient.

One of the most consistent predictors of a better long-term outcome is achieving a complete R0 resection.

Prognosis should therefore be discussed according to the specific cancer, individual anatomy, previous treatment, imaging findings, tumor biology, and likelihood of complete removal, rather than relying on a general pelvic-exenteration survival statistic.

 

Why Specialist-Center Experience Matters

Pelvic exenteration requires more than technical ability to remove pelvic organs.

Successful care requires expertise in:

• Selecting patients who are likely to benefit
• Interpreting complex pelvic imaging
• Assessing the likelihood of complete resection
• Operating safely after previous surgery or radiotherapy
• Multivisceral and extended pelvic resection
• Pelvic sidewall or sacral surgery when required
• Urinary and gastrointestinal reconstruction
• Plastic and reconstructive surgery
• Management of major postoperative complications
• Stoma care
• Rehabilitation and survivorship

Experience therefore matters before surgery as well as during the operation.

A specialist team should be able to determine not only whether an operation can be performed, but also whether it should be performed, what needs to be removed, what can safely be preserved, and whether the expected benefit justifies the surgical and functional consequences.

 

Our Approach to Pelvic Exenteration

Pelvic exenteration should never be performed simply because an extensive operation is technically possible.

Three questions guide the decision:

1. Is surgery likely to provide meaningful oncological benefit?
2. Can complete tumor removal realistically be achieved?
3. What must be removed—and what can safely be preserved—to accomplish that goal?

For patients with locally advanced or recurrent pelvic cancer, this requires careful review of imaging, pathology, previous operations, radiotherapy, systemic treatment, tumor biology, general health, and available treatment alternatives.

When pelvic sidewall or sacral resection, bowel or urinary reconstruction, vascular surgery, or soft-tissue reconstruction may be required, these procedures should be anticipated and coordinated with the appropriate specialists whenever possible.

The objective is to achieve the most effective cancer operation with the least unnecessary functional sacrifice, while preparing each patient realistically for recovery and long-term life after treatment.

 

Why Choose Prof. Yusuf Yıldırım for Pelvic Exenteration Surgery?

Pelvic exenteration requires expertise not only in radical pelvic surgery, but also in patient selection, multivisceral resection, complex pelvic anatomy, reconstruction, and multidisciplinary cancer treatment planning.

As a specialist in Surgical Oncology and Gynecologic Oncology, Prof. Yusuf Yıldırım, MD has experience in the surgical management of complex pelvic, peritoneal, and abdominal cancers.

Each patient is evaluated individually according to the likelihood of complete cancer removal, anatomical extent of disease, previous treatments, expected functional consequences, alternative treatment options, general health, and treatment goals.

When surgery is appropriate, the operative strategy is tailored to the distribution of disease and coordinated with the multidisciplinary specialties required for safe and complete treatment.

 

Second Opinion for Complex or “Unresectable” Pelvic Cancer

Being told that a pelvic cancer is difficult to remove—or has been described as “unresectable”—does not always mean that no surgical option exists.

Advances in extended pelvic resection, pelvic sidewall surgery, sacrectomy, urinary and bowel reconstruction, and multidisciplinary treatment have expanded what may be possible for carefully selected patients.

At the same time, not every technically possible operation provides meaningful benefit.

If your pelvic cancer has been described as unresectable, has returned after previous treatment, or may require pelvic exenteration, specialist review of your imaging, pathology, previous operative reports, radiotherapy records, and systemic treatment history can help determine whether complete surgical removal—or another advanced treatment strategy—may still be appropriate.

The purpose of a second opinion is not necessarily to recommend a larger operation. It is to determine whether surgery offers a realistic benefit, what operation would actually be required, and whether another treatment strategy may be more appropriate.